Ferris Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

Ferris Capital’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$1.45M	Buy	5,551 +33	+0.6%	+$7.83K	0.33%	63
2021 Q4	$1.21M	Sell	5,518 -32	-0.6%	-$6.22K	0.26%	81
2021 Q3	$1.03M	Buy	+5,550	New	+$1.08M	0.22%	95
2021 Q2	–	Sell	-5,694	Closed	-$1.22M	–	191
2021 Q1	$1.22M	Buy	5,694 +32	+0.6%	+$7.03K	0.31%	78
2020 Q4	$1.34M	Sell	5,662 -33	-0.6%	-$7.57K	0.37%	66
2020 Q3	$1.55M	Buy	5,695 +18	+0.3%	+$4.97K	0.5%	52
2020 Q2	$1.65M	Buy	5,677 +22	+0.4%	+$5.96K	0.58%	48
2020 Q1	$1.35M	Sell	5,655 -1,000	-15%	-$229K	0.59%	47
2019 Q4	$1.46M	Buy	6,655 +1,137	+21%	+$230K	0.51%	51
2019 Q3	$935K	Buy	5,518 +1,124	+26%	+$199K	0.34%	70
2019 Q2	$806K	Hold	4,394	–	–	0.3%	82
2019 Q1	$808K	Buy	4,394 +1,085	+33%	+$200K	0.3%	78
2018 Q4	$548K	Sell	3,309 -84	-2%	-$14.6K	0.24%	88
2018 Q3	$654K	Buy	3,393 +46	+1%	+$8.19K	0.26%	79
2018 Q2	$569K	Buy	3,347 +33	+1%	+$5.12K	0.24%	82
2018 Q1	$540K	Buy	3,314 +5	+0.2%	+$817	0.22%	93
2017 Q4	$496K	Hold	3,309	–	–	0.18%	117
2017 Q3	$503K	Buy	3,309 +5	+0.2%	+$753	0.25%	84
2017 Q2	$426K	Buy	+3,304	New	+$398K	0.2%	98

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Ferris Capital's VRTX Position: Q1 2022 in Review

Ferris Capital increased its Vertex Pharmaceuticals (VRTX) stake by 0.6% in Q1 2022, buying an estimated $7.83K and bringing the position to 5,551 shares worth $1.45M. The position accounts for 0.33% of the portfolio, ranked #63.

Ferris Capital first reported a position in VRTX in Q2 2017 and has held it in 19 quarters since. The position peaked at $1.65M in Q2 2020. 1,072 funds tracked by Wall St. Rank hold VRTX as of Q1 2022.

Ferris Capital held 5,551 shares of Vertex Pharmaceuticals worth $1.45M as of Q1 2022.
Ferris Capital bought 33 Vertex Pharmaceuticals shares in Q1 2022, an estimated $7.83K.
Vertex Pharmaceuticals made up 0.33% of Ferris Capital's portfolio in Q1 2022, its #63 holding.
Ferris Capital first reported a position in Vertex Pharmaceuticals in Q2 2017 and has held it in 19 quarters since.
Ferris Capital's Vertex Pharmaceuticals position peaked at $1.65M in Q2 2020.
1,072 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2022.

Based on Ferris Capital's 13F filing for Q1 2022, filed 13 May 2022.